Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2025-09-19 00:00:00 ET · period of report 2025-09-18 · accession 0001470831-25-000223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-19 | 2025-09-18 | CCCC | Adams Kendra | CFO | M - OptEx | $0.00 | +6,250 | 165.1K | +4% | $0 | |
| 2025-09-19 | 2025-09-18 | CCCC | Adams Kendra | CFO | F - Tax | $3.32 | -2,775 | 162.3K | -2% | -$9,213 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-18 | M | A | 6,250 | $0.00 | 165,117 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-18 | F | D | 2,775 | $3.32 | 162,342 | D | — | — |